Patient-Reported Benefits of Acoramidis Across Genotypes in Transthyretin Amyloid Cardiomyopathy: KCCQ and EQ-5D-5L Outcomes From ATTRibute-CM

EMER JOYCE, AHMAD MASRI, LAURA OBICI, PETER VAN-DER-MEER, JAN M. GRIFFIN, KEYUR SHAH, ZUBAIR SHAH, TRACY BERGEMANN, GILLIAN MURTAGH, HEATHER FALVEY, JEAN-FRANÇOIS TAMBY, MARGOT K. DAVIS, FRANCESCO CAPPELLI, STEEN HVITFELDT POULSEN, JOSHUA D. MITCHELL, MAZEN HANNA, BRETT W. SPERRY, NITASHA SARSWAT

Open source

DOI: 10.1016/j.cardfail.2026.09.016
Published: 2026-10
Container: Journal of Cardiac Failure
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.cardfail.2026.09.016,
  title = {Patient-Reported Benefits of Acoramidis Across Genotypes in Transthyretin Amyloid Cardiomyopathy: KCCQ and EQ-5D-5L Outcomes From ATTRibute-CM},
  author = {EMER JOYCE and AHMAD MASRI and LAURA OBICI and PETER VAN-DER-MEER and JAN M. GRIFFIN and KEYUR SHAH and ZUBAIR SHAH and TRACY BERGEMANN and GILLIAN MURTAGH and HEATHER FALVEY and JEAN-FRANÇOIS TAMBY and MARGOT K. DAVIS and FRANCESCO CAPPELLI and STEEN HVITFELDT POULSEN and JOSHUA D. MITCHELL and MAZEN HANNA and BRETT W. SPERRY and NITASHA SARSWAT},
  year = {2026},
  journal = {Journal of Cardiac Failure},
  doi = {10.1016/j.cardfail.2026.09.016},
  url = {https://doi.org/10.1016/j.cardfail.2026.09.016}
}

RIS

TY  - JOUR
TI  - Patient-Reported Benefits of Acoramidis Across Genotypes in Transthyretin Amyloid Cardiomyopathy: KCCQ and EQ-5D-5L Outcomes From ATTRibute-CM
AU  - EMER JOYCE
AU  - AHMAD MASRI
AU  - LAURA OBICI
AU  - PETER VAN-DER-MEER
AU  - JAN M. GRIFFIN
AU  - KEYUR SHAH
AU  - ZUBAIR SHAH
AU  - TRACY BERGEMANN
AU  - GILLIAN MURTAGH
AU  - HEATHER FALVEY
AU  - JEAN-FRANÇOIS TAMBY
AU  - MARGOT K. DAVIS
AU  - FRANCESCO CAPPELLI
AU  - STEEN HVITFELDT POULSEN
AU  - JOSHUA D. MITCHELL
AU  - MAZEN HANNA
AU  - BRETT W. SPERRY
AU  - NITASHA SARSWAT
PY  - 2026
JO  - Journal of Cardiac Failure
DO  - 10.1016/j.cardfail.2026.09.016
UR  - https://doi.org/10.1016/j.cardfail.2026.09.016
ER  -

APA

JOYCE, E., MASRI, A., OBICI, L., VAN-DER-MEER, P., GRIFFIN, J. M., SHAH, K., SHAH, Z., BERGEMANN, T., MURTAGH, G., FALVEY, H., TAMBY, J., DAVIS, M. K., CAPPELLI, F., POULSEN, S. H., MITCHELL, J. D., HANNA, M., SPERRY, B. W., & SARSWAT, N. (2026). Patient-Reported Benefits of Acoramidis Across Genotypes in Transthyretin Amyloid Cardiomyopathy: KCCQ and EQ-5D-5L Outcomes From ATTRibute-CM. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2026.09.016

Source records

crossref · retrieved 2026-11-09T04:32:08.231Z